Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:JNJ
Johnson & Johnson
|
151.22 | 0% | 0% | 363.938,03 | 3,31% | 2,71% |
|
NYSE:MRK
Merck
|
129.29 | -8,69% | 4,69% | 327.466,53 | 2,37% | -19,03% |
|
LSE:AZN
AstraZeneca PLC
|
123.18 | 16,88% | 39,22% | 190.957,95 | 2% | 15,98% |
|
SWX:NOVN
Novartis
|
93.07 | 8,5% | 21,92% | 189.900,62 | 3,57% | 4,67% |
|
SWX:ROG
Roche Holding
|
227.80 | 30,46% | 46,37% | 183.894,9 | 4,26% | 0,43% |
|
NYSE:ABT
Abbott Laboratories
|
104.77 | 1,76% | 14,42% | 182.261,43 | 2,1% | 9,04% |
|
NasdaqGS:AMGN
Amgen
|
308.45 | -11,11% | -2,21% | 165.463,28 | 2,9% | 5,31% |
|
NYSE:PFE
Pfizer
|
28.44 | 9,18% | 39,63% | 161.157,9 | 6% | -9,31% |
|
ENXTPA:SAN
Sanofi
|
92.71 | 14,77% | 33,02% | 115.761,94 | 3,99% | 8,19% |
|
NYSE:MDT
Medtronic
|
83.52 | 27,72% | 40,94% | 110.899,74 | 3,33% | 2,09% |
|
NYSE:BSX
Boston Scientific
|
72.81 | -17,52% | -7,11% | 107.043,79 | 0% | 6,88% |
|
LSE:GSK
GSK
|
18.10 | 5,36% | 20,88% | 73.812,48 | 3,22% | 0,79% |
|
NYSE:BMY
Bristol-Myers Squibb
|
45.06 | 58,04% | 68,14% | 91.341,13 | 5,34% | 13,54% |
|
ASX:CSL
CSL
|
279.92 | 22,63% | 43,58% | 135.272,1 | 1,28% | 7,18% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
67.54 | 21,22% | 30,5% | 84.144,93 | 4,67% | 0,15% |
|
NYSE:SHW
Sherwin Williams
|
315.87 | 2,54% | 15,26% | 80.119,39 | 0,89% | 10,86% |
|
TSE:4568
Daiichi Sankyo Company
|
5422.00 | 0% | 0% | 10.393.676,28 | 1,11% | 0% |
|
TSE:4502
Takeda Pharmaceutical Company
|
4102.00 | 0% | 0% | 6.435.766,66 | 4,75% | 0% |
|
NasdaqGS:BIIB
Biogen
|
225.34 | -13,26% | 2,13% | 32.808,8 | 0% | -10,89% |
|
NYSE:PPG
PPG Industries
|
135.74 | 32,61% | 47,88% | 31.947,92 | 1,92% | 5,32% |
